Baxter International (BAX) Total Current Liabilities (2009 - 2026)
Baxter International's (BAX) quarterly Total Current Liabilities came in at $3.7 billion in Q1 2026, up 6.09% year-on-year from $3.5 billion in Q1 2025, and up 24.34% on a QoQ basis from $3.0 billion in Q4 2025.
Baxter International (BAX) Total Current Liabilities (2009 - 2026) Analysis & Trends
Baxter International (BAX) has 18 years of Total Current Liabilities data on file, last reported at $3.7 billion in Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 6.09% year-over-year to $3.7 billion in Q1 2026; TTM through Mar 2026 was $3.7 billion, a 6.09% increase from a year earlier, with the FY2025 full-year figure at $3.0 billion, down 54.38% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $3.7 billion, up from $3.0 billion in the prior quarter.
- Over the last five years, Total Current Liabilities for BAX reached as high as $6.5 billion in Q4 2024 and fell as low as $2.9 billion in Q2 2025.
- Historically, Total Current Liabilities has averaged $4.8 billion across 5 years, with a median of $4.7 billion in 2022.
- Across the five-year window, Total Current Liabilities surged 67.45% in 2023 and slumped 54.38% in 2025, its largest moves.
- Year by year, Total Current Liabilities stood at $4.7 billion in 2022, then surged by 37.05% to $6.5 billion in 2023, then gained by 0.12% to $6.5 billion in 2024, then slumped by 54.38% to $3.0 billion in 2025, then grew by 24.34% to $3.7 billion in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $3.7 billion in Q1 2026, $3.0 billion in Q4 2025, and $3.8 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 3.00 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 8.51 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 2.54 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 1.35 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 1.80 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 3.35 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 1.91 Bn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 3.69 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.69 Bn |
| Dec 31, 2025 | 2.97 Bn |
| Sep 30, 2025 | 3.78 Bn |
| Jun 30, 2025 | 2.94 Bn |
| Mar 31, 2025 | 3.48 Bn |
| Dec 31, 2024 | 6.51 Bn |
| Sep 30, 2024 | 6.20 Bn |
| Jun 30, 2024 | 6.13 Bn |
| Mar 31, 2024 | 6.37 Bn |
| Dec 31, 2023 | 6.50 Bn |
| Sep 30, 2023 | 6.21 Bn |
| Jun 30, 2023 | 5.77 Bn |
| Mar 31, 2023 | 4.76 Bn |
| Dec 31, 2022 | 4.75 Bn |
| Sep 30, 2022 | 3.71 Bn |
| Jun 30, 2022 | 3.92 Bn |
| Mar 31, 2022 | 3.89 Bn |
| Dec 31, 2021 | 4.24 Bn |
| Sep 30, 2021 | 3.44 Bn |
| Jun 30, 2021 | 3.34 Bn |